ICU Medical : ICUI Investor Presentation UBS Global Healthcare Conference

ICUI

UBS

Global Healthcare Conference

November 13, 2024

Disclosures

ICU Medical: a Global Leader with Focus and Scale

We are a global company focused exclusively on providing IV therapy products and other core critical care products across the continuum of care

Consumables - 44%

Gravity sets, needlefree and specialty IV consumables, vascular access, sharps safety, oncology, and tracheostomy

Systems - 28%

Large volume, syringe, and ambulatory pumps; dedicated consumables; software with EHR interoperability and services

Vital Care - 28%

IV solutions, hemodynamic monitoring systems, temperature management, and respiratory care

3 1. Business unit mix percentages are based on non-GAAP revenues for the year ended December 31, 2023

ICU Medical at a Glance

2023 Revenues - $2.2 Billion

$969 M

Tracheostomy

Vascular Access

$629 M

Syringe Pumps

$615 M

Oncology

Pain Kits

Warming

Ambulatory

Anesthesia &

Respiratory

Critical Care

Infusion Therapy

LVP Infusion

IV Solutions

Consumables

Infusion Systems

Vital Care

Strong Disposables Profile

75%

10%

15%

Single-Use Consumables

Hardware

IV Solutions

Geographic Revenue Mix

68%

32%

US & Canada

OUS

Pro Forma Financial Overview

Share Price (11/8/24)

$176.79

Diluted Shares Outstanding

24.6 M

Diluted Equity Value

$4.35 Billion

Net Debt (9/30/24)

$1.30 Billion

Enterprise Value

$5.65 Billion

4

1.

2023 revenue figures, product mix and geographic mix are based on non-GAAP revenues for the year ended December 31, 2023

2.

Diluted shares outstanding and net debt figures presented in pro forma financial overview table are as of September 30, 2024

Overview - Industry and Company Landscape

Industry:

ICU Medical:

Infusion Consumables: Continuing a Legacy of Growth and Clinical Value

Established Portfolios Built on Quality, Reliability, and Clinical Performance

Infusion Therapy

﹥ Industry-leading Clave gives customers

clinically-preferred IV connector technology

﹥ Broadest catalog of IV sets allows for

standardization of care across a range

of clinical needs

﹥ Vertical integration allows for complete control

6% CAGR

Oncology

2019-20231

Positioned to Continue Stable Growth

6 1. Excludes acquired non-dedicated infusion consumables

Key Consumables Categories Stabilized and Positioned for Opportunities

Stable Foundation of Product Breadth and Clinical Value

Vascular Access

﹥ Diverse portfolio of strong brands: Jelco

,

Powerwand , Port-a-Cath , SuperCath

,

Saf-T Wing , ViaValve

﹥ Stabilized historically-challenged supply,

halting customer attrition and letting us

shift focus to share capture

Ready for Market and Portfolio Advancement

such as catheters with integrated Clave connectors

Tracheostomy

7

Infusion Systems Uniquely Positioned to Grow

2017-2023

Today

Foundation of Innovation

Bringing Meaningfully Novel

and Clinical Value

Technology to a Hungry Market

2024-Beyond

Delivering the Future of the Infusion Systems Market

"I've traveled all over the country

"You don't realize what you don't have,

and I've not used a better pump."

until you see what you can have."

- Charge Nurse, Gen. Med-Surg

- ICU Nurse

8

Strong Foundation to Build More Connected, Collaborative Care

EHR

Clinical

Interoperability

Alarm

Analytics

Forwarding

Biomedical

3rd Party

Reporting

Connectivity

Real-Time

Advanced Clinical

Location Services

LifeShield

Dashboards

IV Performance Platform

Clinician Collaboration

Secure Data Access Across Care

Pharmacists, Clinicians,

Home Care, Hospital,

Medication Safety

Alt Site, IDN

Informatics on All IV Touchpoints

Large Volume

Syringe

PainFuture

Core Value Proposition: Infusion Safety, Clinician Preference, Interoperability Leadership

9

The ICU Medical IV Performance Platform

On Market

Pipeline - New Generation of Precision IV Pumps on Single IT Platform

Large

﹥ Single channel compliment to Plum Duo

﹥ Best of breed with enhanced precision

Volume

﹥ Quietness preferred by clinicians

﹥ Best of breed "family"

Syringe

﹥ Enhanced startup time and time to

occlusion detection

﹥ Ease of use preferred in acute space

Acute

﹥ Comprehensive pain and multi-therapy

Pain

﹥ Complete IV-EHR interoperability

Home

﹥ Connectivity to home

﹥ IV-EHR Interoperability

Health

﹥ Location Services

Informatics

Single, Harmonized IT Platform Across All IV Touchpoints

Informatics, Future-Ready Foundation, Enhance Clinical Experience

10

Disclaimer

ICU Medical Inc. published this content on November 13, 2024, and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on November 14, 2024 at 02:47:08.063.